A randomized, double-blind, placebo-controlled study of the safety and tolerability of Study Drug and its effects on biomarkers in subjects with coronary artery disease.
We work hand-in-hand with our sponsors to develop strategic, flexible approaches that leverage Clinical Informatics, state-of-the-art technologies,…
We’ve contributed to the successful approval of eight marketed cardio-metabolic drugs.
Achieving Challenging Recruitment Goals and Timelines in a Pediatric Type 2 Diabetes Study
Recruiting pediatric patients for type 2 diabetes mellitus (T2DM) studies is extremely challenging. Patients are difficult to identify and often face…